Patent Assignment
Reel/Frame 045305/0865
Merger
Recorded: 2018-03-21
Pages: 6
Assignor
EUREKA THERAPEUTICS, INC.
Executed: 2018-03-05
Assignee
EUREKA THERAPEUTICS, INC.
5858 HORTON STREET, SUITE 370, EMERYVILLE, CALIFORNIA, 94608
Covered Properties
(4)
Antibody Agents Specific for Human CD19 and Uses Thereof
PCT:
PCT/US2016/056325 ↗
Anti-ROR2 Antibodies
Anti-ROR1 Antibodies
Application:
15/654,514 →
Publication:
US 2018/0009892
Antibody Agents Specific for Human CD19 and Uses Thereof
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 30, 2016
From: LIU, HONG; LU, JINGWEI; YANG, ZHIYUAN; LONG, LI
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 040465/0534 →
Assignment of Assignor's Interest
Oct 19, 2017
From: CHEUNG, NAI-KONG V; GUO, HONGFEN; CHENG, MING
To: MEMORIAL SLOANE KETTERING CANCER CENTER
Reel/Frame 043902/0173 →
Assignment of Assignor's Interest
Oct 19, 2017
From: LIU, CHENG; YAN, SU; WANG, PEI
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 043902/0333 →
Assignment of Assignor's Interest
May 2, 2018
From: LIU, CHENG; XU, YIYANG; LIU, HONG; YAN, SU
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 045698/0685 →
Assignment of Assignor's Interest
Jul 6, 2018
From: LIU, HONG; LU, JINGWEI; YANG, ZHIYUAN; LONG, LI
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 046284/0943 →